M&A Deal Summary |
|
|---|---|
| Date | 2018-09-06 |
| Target | sanaplasma AG |
| Sector | Healthcare Services |
| Buyer(s) | Shire |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Life Science |
| Employees | 5,548 |
| Revenue | 6.4B USD (2015) |
Shire plc is a global specialty biopharmaceutical company. Shire plc strive to develop best-in-class therapies across a core of rare disease areas including hematology, immunology, genetic diseases, neuroscience, and internal medicine with growing therapeutic areas in ophthalmics and oncology. Our diversified capabilities enable us to reach patients in more than 100 countries who are struggling to live their lives to the fullest.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 16 |
| Sector: Healthcare Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 14 of 14 |
| Country: Switzerland M&A | 1 of 1 |
| Year: 2018 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-01-04 |
Shire - MRT platform
Dublin, Ireland Shire plc - MRT platform is a mRNA therapy platform. |
Sell | - |